A PHASE Ib, SINGLE- AND MULTIPLE-DOSE, OPEN-LABEL STUDY OF THE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF OBINUTUZUMAB IN ADULTS WITH END-STAGE RENAL DISEASE AND HYPERSENSITIZATION AWAITING RENAL TRANSPLANTATION
|Effective start/end date||7/15/15 → 5/31/18|
- GENENTECH, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.